Pharma, device groups oppose FDA's planned drug to device transition
Regulatory NewsJoanne S. Eglovitch.jpg.aspx?lang=en-us&width=300&height=200&ext=.jpg)
Combination products/companion diagnosticsComplianceNorth AmericaQuality Assurance and ControlRegulatory Intelligence/PolicyRegulatory NewsJoanne S. EglovitchCombination products/companion diagnosticsComplianceNorth AmericaQuality Assurance and ControlRegulatory Intelligence/Policy